dc.creatorMick, Gérard
dc.creatorCorrea-Illanes, Gerardo
dc.date.accessioned2019-03-11T13:04:02Z
dc.date.available2019-03-11T13:04:02Z
dc.date.created2019-03-11T13:04:02Z
dc.date.issued2012
dc.identifierCurrent Medical Research and Opinion, Volumen 28, Issue 6, 2018, Pages 937-951
dc.identifier03007995
dc.identifier14734877
dc.identifier10.1185/03007995.2012.690339
dc.identifierhttps://repositorio.uchile.cl/handle/2250/165596
dc.description.abstractBackground: The topical 5 lidocaine medicated plaster is recommended as first-line treatment for localized peripheral neuropathic pain. Scope: In order to provide an overview of the efficacy and safety of the lidocaine plaster in the treatment of different neuropathic pain conditions, all efficacy and safety studies (randomized, controlled, or open-label with well described methodology), case reports, and pharmacological studies on the lidocaine plaster retrieved from a PubMed literature research (1960-March 2012) plus additional references identified from retrieved articles were included. Findings: The lidocaine plaster is efficacious in the treatment of neuropathic pain symptoms associated with previous herpes zoster infection. Results from a large open-label controlled study suggest that the lidocaine plaster could be at least as effective as systemic pregabalin in the treatment of postherpetic neuralgia and painful diabetic polyneuropathy. Open-label studies indicate efficacy in th
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceCurrent Medical Research and Opinion
dc.subject5 lidocaine medicated plaster
dc.subjectChronic pain
dc.subjectNeuropathic pain
dc.subjectPain management
dc.subjectTopical pain treatment
dc.titleTopical pain management with the 5 lidocaine medicated plaster a review
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución